'Call to Action' for DPYD Testing Before Fluorouracil Chemo

A 'call to action' has been issued for clinicians and US guidelines committees to reevaluate the utility of DPYD testing before administering fluoropyrimidine (FP) chemotherapy, but not everyone agrees.

Related Keywords

California , United States , Ann Arbor , Michigan , New Hampshire , United Kingdom , San Francisco , American , Daniell Hertz , Alan Venook , University Of California , American Society Of Clinical Oncology , Drug Administration , University Of Michigan College Pharmacy , Dartmouth Institute , Geisel School Of Medicine , National Cancer Centers Network , Department Of Clinical Pharmacy , Helen Diller Family Comprehensive Cancer Center , Clinical Pharmacy , Michigan College , Guidelines Version , Medscape Medical News , American Society , Clinical Oncology , Geisel School , Genomics , Genomic Medicine , Edicine Genomic , Toxicology , Clinical Guidelines , Guidelines , Chemotherapy , Adjuvant Chemotherapy , Colon Cancer , Alignant Colon Neoplasm , Colorectal Cancer , Cancer , Alignant Neoplasia , Arcinoma , Practice Management , Europe , European , Insurance , Genetics , Intensive Care Unit Icu , Intensive Care Unit , Icu , Intensive Care , Biomarker , Iological Marker , , Diet , Fellowship , Yellows ,